Press Release

Lavender oil may contribute to abnormal breast growth in young girls

Washington, DC August 28, 2019
Abnormal breast growth in young girls is linked to lavender oil exposure, according to a recent study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Previous research has associated breast growth in boys with lavender-containing fragrances. This study, “Lavender Products Associated With Premature Thelarche and Prepubertal Gynecomastia: Case Reports and EDC Activities,” is the first to report abnormal breast growth in young girls.

The researchers found that breast growth in young girls and boys resolved after discontinuing lavender-containing fragranced products. They also determined that certain components of essential oils mimic estrogen and block testosterone, indicating that essential oils could be a source for the breast growth observed in these cases.

“The public should be aware of these findings and consider all evidence before deciding when to use essential oils,” said study lead investigator J. Tyler Ramsey, a second year medical student at Campbell University and postbaccalaureate research fellow at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health. “It’s also important that physicians are aware that lavender and tea tree oils contain endocrine-disrupting chemicals and should be considered in the evaluation of premature breast development in young girls and boys, and the swelling of breast tissue in adult men.”

“It appears that essential oil products have the potential to cause premature breast growth in young girls and boys, so it may be best to discontinue using them on children,” Ramsey said.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom

Media Contacts

Colleen Williams Associate Director, Communications and Media Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.